Family Office Briefing on research byTranswestern·Jun 7, 2024
Houston Life Sciences Research Report - Winter-Spring 2024
Houston life sciences market sees significant funding and development in 2024 — family offices should consider co-GP opportunities with established operators.
Key Metrics
| Metric | Value |
|---|---|
| Houston CPRIT Funding | 117.5million |
| Houston Venture Capital Funding | 362.8million |
| Houston NIH Funding | 812.6million |
Metrics extracted from the source report and independently fact-checked. Method →
Full report
Transwestern
Building a thesis around Houston? Share it confidentially with the Thesis Exchange — we pair you anonymously with family offices running adjacent life science strategies.
Peer Network · By Invitation
The Thesis Exchange
Share an investment thesis in confidence. We pair you anonymously with up to two other family offices running adjacent strategies. Reviewed by Gallium's editorial team. No vendor pitch.